Sexually Transmitted Infections (STIs) Global Market Report 2024

Description

“Sexually Transmitted Infections (STIs) Global Market Report 2024 ” from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on sexually transmitted infections (stis) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
Understand how the market has been affected by the COVID-19 and how it is responding as the impact of the virus abates.
Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
Measure the impact of high global inflation on market growth.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for sexually transmitted infections (stis)? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? “The sexually transmitted infections (stis) market global report ” from The Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

Scope

Markets Covered:

1) By Type: Human Immunodeficiency Virus (HIV); Human Papilloma Virus (HPV); Gonorrhea; Syphilis; Other Types
2) By Treatment: Antibiotics; Antiviral
3) By Location Of Testing: Laboratory Testing; Point-Of-Care (POC) Testing
4) By Route Of Administration: Oral; Parenteral; Other Route Of Administration
5) By End-Users: Hospitals; Specialty Clinics; Homecare; Other End-Users
Companies Mentioned: Pfizer Inc.; Johnson & Johnson; Roche Holdings AG; Merck & Co Inc.; AbbVie Inc.
Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Time series: Five years historic and ten years forecast.
Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
Delivery format: PDF, Word and Excel Data Dashboard.

Executive Summary

Sexually transmitted infections (STIs), also referred to as sexually transmitted diseases (STDs), are a group of illnesses caused by viruses, bacteria, and parasites that are transmitted from one individual to another through sexual contact. These infections can be spread through vaginal, anal, and oral sexual intercourse, as well as through skin-to-skin contact.

The primary types of sexually transmitted infections (STIs) include human immunodeficiency virus (HIV), human papillomavirus (HPV), gonorrhea, syphilis, and others. Human Immunodeficiency Virus (HIV) is a virus that affects the body's immune system by targeting a specific type of white blood cell that plays a crucial role in resisting infections. Various treatments, including antibiotics and antivirals, are available, with testing conducted in diverse settings such as laboratory testing and point-of-care (POC) testing. These treatments are administered via oral, parenteral, and other routes and are commonly provided in hospitals, specialty clinics, homecare, and other healthcare settings.

The sexually transmitted infections (STIs) market research report is one of a series of new reports from The Business Research Company that provides sexually transmitted infections (STIs) market statistics, including sexually transmitted infections (STIs) industry global market size, regional shares, competitors with a sexually transmitted infections (STIs) market share, detailed sexually transmitted infections (STIs) market segments, market trends and opportunities and any further data you may need to thrive in the sexually transmitted infections (STIs) industry. This sexually transmitted infections (STIs) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The sexually transmitted infections (stis) market size has grown rapidly in recent years. It will grow from $56.17 billion in 2023 to $63.69 billion in 2024 at a compound annual growth rate (CAGR) of 13.4%. The growth in the historic period can be attributed to behavioral factors, education and awareness, healthcare access, antibiotic development.

The sexually transmitted infections (stis) market size is expected to see rapid growth in the next few years. It will grow to $100.66 billion in 2028 at a compound annual growth rate (CAGR) of 12.1%. The growth in the forecast period can be attributed to emerging sti strains, vaccination initiatives, telemedicine and at-home testing, sexual health equity. Major trends in the forecast period include rise of antimicrobial resistance, pre-exposure prophylaxis (prep), sti self-management, enhanced sexual education.

Government-driven initiatives are playing a pivotal role in fueling the growth of the sexually transmitted infections (STIs) market. These government initiatives encompass a range of programs and policies aimed at raising awareness of STIs and are expected to be a driving force behind the market's expansion. These programs are specifically designed to address the challenges associated with STIs and typically involve allocating funds for public education campaigns to increase STI awareness. Additionally, government initiatives may include the development of vaccines to prevent certain STIs and the provision of free or low-cost screening and testing services. A notable example is the Disease Intervention Specialist (DIS) program launched by the Springfield-Greene County Health department in April 2023, in collaboration with the Missouri Department of Health and Senior Services (Missouri DHSS). This program focuses on countering the increasing prevalence of sexually transmitted infections, with a primary emphasis on syphilis and HIV. The DIS program involves experts who proactively reach out to individuals who have tested positive for these infections, facilitating access to treatment and ensuring contact tracing to raise awareness about potential infection. Therefore, government initiatives are expected to be a driving factor for the growth of the sexually transmitted infections (STIs) market.

The sexually transmitted infections (STIs) market is also witnessing growth due to the rising prevalence of unprotected sex. This shift in behavior indicates a trend where individuals engage in sexual activities without the use of protective measures like condoms, contributing to the increased transmission of STIs. As per data from the Centers for Disease Control and Prevention (CDC) in the United States, 30% of high school students had engaged in sexual intercourse in 2021. Alarmingly, 48% of these students did not use condoms during their most recent sexual encounter, and only 5% had been tested for sexually transmitted diseases within the past year. This culture of unprotected sex is driving the growth of the sexually transmitted infections (STIs) market.

High treatment costs are adversely impacting the growth of the sexually transmitted infections market during the forecast period. The elevated costs of treatment can exacerbate health disparities, as individuals with limited financial resources may face significant obstacles to accessing timely and effective STI care. This can contribute to disparities in STI prevalence and outcomes. For example, according to the American Hospital Association, a professional organization, hospital prices increased by 2.1% over the year leading up to February 2022. Therefore, the high cost of treatment is impeding the growth of the sexually transmitted infections market.

Major companies within the sexually transmitted infections (STIs) market are pioneering innovative products that incorporate fluorescent PCR technology to gain a competitive edge in the market. Fluorescent PCR (Polymerase Chain Reaction) technology is a molecular biology technique used to detect and quantify specific DNA sequences in a biological sample. For instance, in March 2023, Jiangsu Bioperfectus Technologies Co. Ltd., a China-based provider of molecular diagnostic solutions, introduced two new polymerase chain reaction (PCR) kits including the Mycoplasma Hominis Real-Time PCR Kit and the Treponema Pallidum Real-Time PCR Kit. These kits offer a comprehensive PCR solution for the early diagnosis of sexually transmitted infections, which affect a significant population. The BioPerfectus Mycoplasma Hominis Real-Time PCR Kit is a reagent that utilizes fluorescent PCR technology to detect Mycoplasma hominis in human male urethral swabs, female cervical or vaginal swabs, and urine samples. The BioPerfectus Treponema Pallidum Real-Time PCR Kit is designed to detect treponema pallidum nucleic acid in human serum and plasma.

In February 2023, Caraway Health, a US-based provider of digital healthcare services for Generation Z, entered into a partnership with Ash Wellness Inc. The collaboration addresses the surge in sexually transmitted infections (STIs) on university campuses among Generation Z. This partnership equips Generation Z with the tools necessary to prioritize their sexual well-being on their own terms. Ash Wellness Inc. is a US-based provider of remote diagnostic solutions, including home HIV and STI testing.

Major players in the sexually transmitted infections (stis) market are Pfizer Inc., Johnson & Johnson, Roche Holdings AG, Merck & Co Inc., AbbVie Inc., Novartis AG, Sanofi SA, Bristol-Myers Squibb, Astra Zeneca Pharmaceuticals LP, GlaxoSmithKline PLC, Takeda Pharmaceutical Company Limited, Gilead Sciences Inc., Viatris Inc., Teva Pharmaceutical Industries Ltd., Astellas Pharma Inc., Daiichi Sankyo Co. Ltd., Hetero Drugs Ltd., Eisai Co. Ltd., Boehringer Ingelheim Group, Sun Pharmaceutical Industries Ltd., Lupin Limited, Dr. Reddy's Laboratories, Wockhardt Ltd., Zydus Lifescience Ltd., Glenmark Pharmaceuticals Ltd., Cipla Ltd., Torrent Pharmaceuticals Ltd., Otsuka Pharmaceutical Co. Ltd.

North America was the largest region in the sexually transmitted infection (STIs) market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in sexually transmitted infections (STIs) report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the sexually transmitted infections (STIs) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The sexually transmitted infections (STIs) market consists of revenues earned by entities by providing services such as treatment, testing, awareness programs and diagnosis. The market value includes the value of related goods sold by the service provider or included within the service offering. The sexually transmitted infections (STIs) market also includes the sales of treatments such as testing kits, vaccines and medication. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Product Code: r12393

1. Executive Summary

2. Sexually Transmitted Infections (STIs) Market Characteristics

3. Sexually Transmitted Infections (STIs) Market Trends And Strategies

4. Sexually Transmitted Infections (STIs) Market - Macro Economic Scenario

4.1. Impact Of High Inflation On The Market
4.2. Ukraine-Russia War Impact On The Market
4.3. COVID-19 Impact On The Market

5. Global Sexually Transmitted Infections (STIs) Market Size and Growth

5.1. Global Sexually Transmitted Infections (STIs) Market Drivers and Restraints
- 5.1.1. Drivers Of The Market
- 5.1.2. Restraints Of The Market
5.2. Global Sexually Transmitted Infections (STIs) Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
5.3. Global Sexually Transmitted Infections (STIs) Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Sexually Transmitted Infections (STIs) Market Segmentation

6.1. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Human Immunodeficiency Virus (HIV)
Human Papilloma Virus (HPV)
Gonorrhea
Syphilis
Other Types
6.2. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Antibiotics
Antiviral
6.3. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Location Of Testing, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Laboratory Testing
Point-Of-Care (POC) Testing
6.4. Global Sexually Transmitted Infections (STIs) Market, Segmentation By Route Of Administration, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Oral
Parenteral
Other Route Of Administration
6.5. Global Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
Hospitals
Specialty Clinics
Homecare
Other End-Users

7. Sexually Transmitted Infections (STIs) Market Regional And Country Analysis

7.1. Global Sexually Transmitted Infections (STIs) Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
7.2. Global Sexually Transmitted Infections (STIs) Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Sexually Transmitted Infections (STIs) Market

8.1. Asia-Pacific Sexually Transmitted Infections (STIs) Market Overview
Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.3. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
8.4. Asia-Pacific Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Sexually Transmitted Infections (STIs) Market

9.1. China Sexually Transmitted Infections (STIs) Market Overview
9.2. China Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.3. China Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
9.4. China Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Sexually Transmitted Infections (STIs) Market

10.1. India Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.2. India Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
10.3. India Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Sexually Transmitted Infections (STIs) Market

11.1. Japan Sexually Transmitted Infections (STIs) Market Overview
11.2. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.3. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
11.4. Japan Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Sexually Transmitted Infections (STIs) Market

12.1. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.2. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
12.3. Australia Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Sexually Transmitted Infections (STIs) Market

13.1. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.2. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
13.3. Indonesia Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Sexually Transmitted Infections (STIs) Market

14.1. South Korea Sexually Transmitted Infections (STIs) Market Overview
14.2. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.3. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
14.4. South Korea Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Sexually Transmitted Infections (STIs) Market

15.1. Western Europe Sexually Transmitted Infections (STIs) Market Overview
15.2. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.3. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
15.4. Western Europe Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Sexually Transmitted Infections (STIs) Market

16.1. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.2. UK Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
16.3. UK Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Sexually Transmitted Infections (STIs) Market

17.1. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.2. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
17.3. Germany Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Sexually Transmitted Infections (STIs) Market

18.1. France Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.2. France Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
18.3. France Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Sexually Transmitted Infections (STIs) Market

19.1. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.2. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
19.3. Italy Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Sexually Transmitted Infections (STIs) Market

20.1. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.2. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
20.3. Spain Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Sexually Transmitted Infections (STIs) Market

21.1. Eastern Europe Sexually Transmitted Infections (STIs) Market Overview
21.2. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.3. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
21.4. Eastern Europe Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Sexually Transmitted Infections (STIs) Market

22.1. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.2. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
22.3. Russia Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Sexually Transmitted Infections (STIs) Market

23.1. North America Sexually Transmitted Infections (STIs) Market Overview
23.2. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.3. North America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
23.4. North America Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Sexually Transmitted Infections (STIs) Market

24.1. USA Sexually Transmitted Infections (STIs) Market Overview
24.2. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.3. USA Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
24.4. USA Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Sexually Transmitted Infections (STIs) Market

25.1. Canada Sexually Transmitted Infections (STIs) Market Overview
25.2. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.3. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
25.4. Canada Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Sexually Transmitted Infections (STIs) Market

26.1. South America Sexually Transmitted Infections (STIs) Market Overview
26.2. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.3. South America Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
26.4. South America Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Sexually Transmitted Infections (STIs) Market

27.1. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.2. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
27.3. Brazil Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Sexually Transmitted Infections (STIs) Market

28.1. Middle East Sexually Transmitted Infections (STIs) Market Overview
28.2. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.3. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
28.4. Middle East Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Sexually Transmitted Infections (STIs) Market

29.1. Africa Sexually Transmitted Infections (STIs) Market Overview
29.2. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.3. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By Treatment, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
29.4. Africa Sexually Transmitted Infections (STIs) Market, Segmentation By End-Users, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Sexually Transmitted Infections (STIs) Market Competitive Landscape And Company Profiles

30.1. Sexually Transmitted Infections (STIs) Market Competitive Landscape
30.2. Sexually Transmitted Infections (STIs) Market Company Profiles
- 30.2.1. Pfizer Inc.
  - 30.2.1.1. Overview
  - 30.2.1.2. Products and Services
  - 30.2.1.3. Strategy
  - 30.2.1.4. Financial Performance
- 30.2.2. Johnson & Johnson
  - 30.2.2.1. Overview
  - 30.2.2.2. Products and Services
  - 30.2.2.3. Strategy
  - 30.2.2.4. Financial Performance
- 30.2.3. Roche Holdings AG
  - 30.2.3.1. Overview
  - 30.2.3.2. Products and Services
  - 30.2.3.3. Strategy
  - 30.2.3.4. Financial Performance
- 30.2.4. Merck & Co Inc.
  - 30.2.4.1. Overview
  - 30.2.4.2. Products and Services
  - 30.2.4.3. Strategy
  - 30.2.4.4. Financial Performance
- 30.2.5. AbbVie Inc.
  - 30.2.5.1. Overview
  - 30.2.5.2. Products and Services
  - 30.2.5.3. Strategy
  - 30.2.5.4. Financial Performance

31. Sexually Transmitted Infections (STIs) Market Other Major And Innovative Companies

31.1. Novartis AG
31.2. Sanofi SA
31.3. Bristol-Myers Squibb
31.4. Astra Zeneca Pharmaceuticals LP
31.5. GlaxoSmithKline plc
31.6. Takeda Pharmaceutical Company Limited
31.7. Gilead Sciences Inc.
31.8. Viatris Inc.
31.9. Teva Pharmaceutical Industries Ltd.
31.10. Astellas Pharma Inc.
31.11. Daiichi Sankyo Co. Ltd.
31.12. Hetero Drugs Ltd.
31.13. Eisai Co. Ltd.
31.14. Boehringer Ingelheim Group
31.15. Sun Pharmaceutical Industries Ltd.

32. Global Sexually Transmitted Infections (STIs) Market Competitive Benchmarking

33. Global Sexually Transmitted Infections (STIs) Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Sexually Transmitted Infections (STIs) Market

35. Sexually Transmitted Infections (STIs) Market Future Outlook and Potential Analysis

35.1 Sexually Transmitted Infections (STIs) Market In 2028 - Countries Offering Most New Opportunities
35.2 Sexually Transmitted Infections (STIs) Market In 2028 - Segments Offering Most New Opportunities
35.3 Sexually Transmitted Infections (STIs) Market In 2028 - Growth Strategies
- 35.3.1 Market Trend Based Strategies
- 35.3.2 Competitor Strategies

36. Appendix

36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer